The Serce Dziecka Foundation is launching the InteliCardio training and research project. This initiative combines the fields of medicine and artificial intelligence (AI), offering the potential for a breakthrough in diagnosing congenital heart defects (CHD) in children.
Every day in Poland, 10 children are born with congenital heart defects, and one in five of them has a critical defect. Unfortunately, the low detection rate of these defects (only 30-50%) often leads to tragic consequences. With InteliCardio, there is a chance to change this! Artificial intelligence will aid in faster and more accurate detection of defects, enabling early intervention and saving many children’s lives.
The project was developed in collaboration with leading scientists in the field of congenital heart defect treatment (CHD). Its goal is to enhance the competencies and knowledge of doctors regarding the potential future use of AI to improve the diagnosis of congenital heart defects (CHD). The ability to utilize innovative IT tools will be crucial in the future for raising medical care standards and advancing the professional development of medical staff. Therefore, actions in this area must begin today.
Participants in the project—neonatologists and obstetricians—will learn how AI technologies can contribute to the earlier detection of defects, the potential of developed solutions to increase diagnostic accuracy, and the rapid processing of medical data.
We have invited leading Polish institutions specializing in congenital heart defects in fetuses to participate in the project:
The project will begin on August 30, 2024, with training at the PRO-FAMILIA Specialist Hospital.
The initiative is under the patronage and receives substantive support from the Polish Society of Prenatal Cardiology. The technologies used in the project are provided by a Polish company specializing in the use of AI for CHD diagnosis.
Detailed information about the project is available at www.intelicardio.pl.
We are proud to announce that our Ultra Echo Scan (UES) technology has won the grand prize in the prestigious…
The Institute of Mother and Child hosted an extraordinary meeting on the future of technology in healthcare, attended by distinguished…
The Intelicardio project “Artificial intelligence in the diagnosis of congenital heart defects – future practical application” carried out by our…
On January 17, 2025, the Institute of Mother and Child in Warsaw will once again host a training as part…
It is a great honor and satisfaction for us. The competition is the most important event in Poland dedicated to…
Our project was one of the three finalists in the transformation partner/solution provider category.The Children’s Hospital of the Future” Competition…
At the Medica 2024 trade fair in Dusseldorf (11-14 November 2024), we will present our project Ultra Echo Scan (UES)….
The technology used in our UES project has been appreciated by one of the largest startups and innovation platforms supporting…
Ultra Echo Scan (UES) and UPS Ultra Pregna Scan (UPS) were included in the prestigious report Top Disruptors in Healthcare…
Founder and board member Prometheus Med Tech.AI Tomasz Bartosiak is a speaker on the AI for Health panel at the…
We had the privilege of attending the 2024 World Congress, hosted by the leading international organization dedicated to promoting education…
The organizer of the Symposium was Dr. Witold Błaż from the Provincial Hospital No. 2. Saint Jadwiga Queen in Rzeszów….
